Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., . . . Perren, T. J. (2015). Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): Overall survival results of a phase 3 randomised trial. Lancet Oncol.
シカゴスタイル引用形Oza, Amit M., et al. "Standard Chemotherapy With or Without Bevacizumab for Women With Newly Diagnosed Ovarian Cancer (ICON7): Overall Survival Results of a Phase 3 Randomised Trial." Lancet Oncol 2015.
MLA引用形式Oza, Amit M., et al. "Standard Chemotherapy With or Without Bevacizumab for Women With Newly Diagnosed Ovarian Cancer (ICON7): Overall Survival Results of a Phase 3 Randomised Trial." Lancet Oncol 2015.
警告: この引用は必ずしも正確ではありません.